Canlyniadau Chwilio - David T. Teachey

Mireinio'r Canlyniadau
  1. 1
    Unmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome (ALPS)

    Unmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome (ALPS) gan David T. Teachey

    Cyhoeddwyd 2004
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    New advances in the diagnosis and treatment of autoimmune lymphoproliferative syndrome

    New advances in the diagnosis and treatment of autoimmune lymphoproliferative syndrome gan David T. Teachey

    Cyhoeddwyd 2011
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Predicting relapse risk in childhood acute lymphoblastic leukaemia

    Predicting relapse risk in childhood acute lymphoblastic leukaemia gan David T. Teachey, Stephen P. Hunger

    Cyhoeddwyd 2013
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Diagnosis and Management of Autoimmune Cytopenias in Childhood

    Diagnosis and Management of Autoimmune Cytopenias in Childhood gan David T. Teachey, Michele P. Lambert

    Cyhoeddwyd 2013
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    T-cell acute lymphoblastic leukemia

    T-cell acute lymphoblastic leukemia gan Elizabeth A. Raetz, David T. Teachey

    Cyhoeddwyd 2016
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    Autoimmune lymphoproliferative syndrome: more than a FAScinating disease

    Autoimmune lymphoproliferative syndrome: more than a FAScinating disease gan Karen L. Bride, David T. Teachey

    Cyhoeddwyd 2017
    Cael y testun llawn Cael y testun llawn
    Pré-impressão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Comparative features and outcomes between paediatric T-cell and B-cell acute lymphoblastic leukaemia

    Comparative features and outcomes between paediatric T-cell and B-cell acute lymphoblastic leukaemia gan David T. Teachey, Ching‐Hon Pui

    Cyhoeddwyd 2019
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    How I treat newly diagnosed T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma in children

    How I treat newly diagnosed T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma in children gan David T. Teachey, David O’Connor

    Cyhoeddwyd 2019
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome

    Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome gan Chelsea Kotch, David M. Barrett, David T. Teachey

    Cyhoeddwyd 2019
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Riding the storm: managing cytokine-related toxicities in CAR-T cell therapy

    Riding the storm: managing cytokine-related toxicities in CAR-T cell therapy gan Andrew D. Hughes, David T. Teachey, Caroline Diorio

    Cyhoeddwyd 2024
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Toxicity management for patients receiving novel T-cell engaging therapies

    Toxicity management for patients receiving novel T-cell engaging therapies gan David M. Barrett, David T. Teachey, Stephan A. Grupp

    Cyhoeddwyd 2013
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS)

    Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS) gan David T. Teachey, Alix E. Seif, Stephan A. Grupp

    Cyhoeddwyd 2009
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    Mammalian target of rapamycin inhibitors and their potential role in therapy in leukaemia and other haematological malignancies

    Mammalian target of rapamycin inhibitors and their potential role in therapy in leukaemia and other haematological malignancies gan David T. Teachey, Stephan A. Grupp, Valerie I. Brown

    Cyhoeddwyd 2009
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    Targeting the PI3K/mTOR Pathway in Pediatric Hematologic Malignancies

    Targeting the PI3K/mTOR Pathway in Pediatric Hematologic Malignancies gan Sarah K. Tasian, David T. Teachey, Susan R. Rheingold

    Cyhoeddwyd 2014
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    Cellular therapy: Immune‐related complications

    Cellular therapy: Immune‐related complications gan Joseph H. Oved, David M. Barrett, David T. Teachey

    Cyhoeddwyd 2019
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    Optimizing therapy in the modern age: differences in length of maintenance therapy in acute lymphoblastic leukemia

    Optimizing therapy in the modern age: differences in length of maintenance therapy in acute lymphoblastic leukemia gan David T. Teachey, Stephen P. Hunger, Mignon L. Loh

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    Targeting the PI3K/AKT/mTOR Signaling Axis in Children with Hematologic Malignancies

    Targeting the PI3K/AKT/mTOR Signaling Axis in Children with Hematologic Malignancies gan David Barrett, Valerie I. Brown, Stephan A. Grupp, David T. Teachey

    Cyhoeddwyd 2012
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia

    CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia gan Shannon L. Maude, David T. Teachey, David L. Porter, Stephan A. Grupp

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    Managing Cytokine Release Syndrome Associated With Novel T Cell-Engaging Therapies

    Managing Cytokine Release Syndrome Associated With Novel T Cell-Engaging Therapies gan Shannon L. Maude, David M. Barrett, David T. Teachey, Stephan A. Grupp

    Cyhoeddwyd 2014
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  20. 20
    Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit 'ALL'

    Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit 'ALL' gan David T. Teachey, Michael R. Bishop, David G. Maloney, Stephan A. Grupp

    Cyhoeddwyd 2018
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: